Literature DB >> 12022872

Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

Pauline F Marx1, Philip E Dawson, Bonno N Bouma, Joost C M Meijers.   

Abstract

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates the fibrin cofactor function of tissue-type plasminogen activator-mediated plasmin formation and subsequently fibrin degradation. In the present study, we focused on the role of plasmin in the regulation of TAFIa activity. Upon incubation with plasmin, TAFIa activity was generated, which was unstable at 37 degrees C. Analysis of the cleavage pattern showed that TAFI was cleaved at Arg(92), releasing the activation peptide from the 35.8-kDa catalytic domain. The presence of the 35.8-kDa fragment paralleled the time course of generation and loss of TAFIa activity. This suggested that, in the presence of plasmin, TAFIa is probably inactivated by proteolysis rather than by conformational instability. TAFI was also cleaved at Arg(302), Lys(327), and Arg(330), resulting in a approximately 44.3-kDa fragment and several smaller fragments. The 44.3-kDa fragment is no longer activatable since it lacks part of the catalytic center. We concluded that plasmin can cleave at several sites in TAFI and that this contributes to the regulation of TAFI and TAFIa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022872     DOI: 10.1021/bi015982e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

Authors:  Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

2.  Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates.

Authors:  Zuzana Valnickova; Laura Sanglas; Joan L Arolas; Steen V Petersen; Christine Schar; Daniel Otzen; Francesc X Aviles; F Xavier Gomis-Rüth; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

Review 3.  Substrates of the plasminogen activator protease of Yersinia pestis.

Authors:  Adam J Caulfield; Wyndham W Lathem
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer.

Authors:  Mehmet Eser; Metin Kement; Salim Balin; Cihan Coskun; Umut Kefeli; Mahmut Gumus; Yunus Emre Altuntas; Necmi Kurt; Alparslan Mayadagli
Journal:  World J Surg Oncol       Date:  2012-08-31       Impact factor: 2.754

5.  Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis.

Authors:  Rojin Park; Jaewoo Song; Seong Soo A An
Journal:  Korean J Hematol       Date:  2010-12-31

Review 6.  Measuring fibrinolysis: from research to routine diagnostic assays.

Authors:  C Longstaff
Journal:  J Thromb Haemost       Date:  2018-02-17       Impact factor: 5.824

7.  Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).

Authors:  Zuzana Valnickova; Morten Thaysen-Andersen; Peter Højrup; Trine Christensen; Kristian W Sanggaard; Torsten Kristensen; Jan J Enghild
Journal:  BMC Biochem       Date:  2009-05-05       Impact factor: 4.059

Review 8.  Fibrinolytic and coagulative activities of Yersinia pestis.

Authors:  Timo K Korhonen; Johanna Haiko; Liisa Laakkonen; Hanna M Järvinen; Benita Westerlund-Wikström
Journal:  Front Cell Infect Microbiol       Date:  2013-07-26       Impact factor: 5.293

9.  A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.

Authors:  Tara M Stanne; Maja Olsson; Erik Lorentzen; Annie Pedersen; Anders Gummesson; Ann Gils; Katarina Jood; Gunnar Engström; Olle Melander; Paul J Declerck; Christina Jern
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

Review 10.  Regulation of plasminogen activation on cell surfaces and fibrin.

Authors:  T Urano; F J Castellino; Y Suzuki
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.